Adell Harriman & Carpenter’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,775
Closed -$573K 142
2019
Q3
$573K Sell
5,775
-4,350
-43% -$413K 0.1% 105
2019
Q2
$936K Sell
10,125
-2,090
-17% -$198K 0.17% 88
2019
Q1
$1.15M Sell
12,215
-8,015
-40% -$701K 0.22% 83
2018
Q4
$1.3M Sell
20,230
-6,780
-25% -$500K 0.29% 77
2018
Q3
$2.42M Sell
27,010
-1,270
-4% -$112K 0.45% 59
2018
Q2
$2.25M Buy
28,280
+7,780
+38% +$646K 0.45% 60
2018
Q1
$1.83M Sell
20,500
-1,635
-7% -$157K 0.38% 69
2017
Q4
$2.31M Sell
22,135
-6,234
-22% -$703K 0.49% 54
2017
Q3
$4.14M Buy
28,369
+125
+0.4% +$17K 0.9% 44
2017
Q2
$3.67M Buy
28,244
+465
+2% +$57K 0.83% 44
2017
Q1
$3.46M Sell
27,779
-470
-2% -$56.2K 0.79% 49
2016
Q4
$3.27M Sell
28,249
-2,230
-7% -$248K 0.81% 47
2016
Q3
$3.19M Sell
30,479
-2,450
-7% -$265K 0.81% 49
2016
Q2
$3.25M Sell
32,929
-1,700
-5% -$176K 0.85% 46
2016
Q1
$3.47M Sell
34,629
-2,148
-6% -$221K 0.93% 44
2015
Q4
$4.4M Buy
36,777
+3,520
+11% +$407K 1.18% 34
2015
Q3
$3.6M Sell
33,257
-1,736
-5% -$215K 1.06% 39
2015
Q2
$4.05M Buy
34,993
+1,511
+5% +$173K 1.04% 35
2015
Q1
$3.86M Buy
33,482
+3,095
+10% +$370K 1.02% 36
2014
Q4
$3.4M Buy
30,387
+1,189
+4% +$125K 0.93% 42
2014
Q3
$2.51M Hold
29,198
0.69% 51
2014
Q2
$2.51M Buy
29,198
+1,640
+6% +$125K 0.69% 51
2014
Q1
$1.92M Buy
27,558
+10,508
+62% +$832K 0.57% 59
2013
Q4
$1.44M Buy
17,050
+5,650
+50% +$447K 0.45% 63
2013
Q3
$879K Buy
+11,400
New +$799K 0.25% 76

Other funds holding CELG

Adell Harriman & Carpenter's CELG Position: Q4 2019 in Review

Adell Harriman & Carpenter sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,775 shares — an estimated $573K sold.

Adell Harriman & Carpenter first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $4.4M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Adell Harriman & Carpenter reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Adell Harriman & Carpenter sold 5,775 Celgene Corp shares in Q4 2019, an estimated $573K.
  • Adell Harriman & Carpenter first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
  • Adell Harriman & Carpenter's Celgene Corp position peaked at $4.4M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Adell Harriman & Carpenter's 13F filing for Q4 2019, filed 7 Feb 2020.